BCL2L1 and melanoma: This is consistent with previous studies showing that the co-inhibition of Mcl-1 and other anti-apoptotic proteins, such as Bcl-xL, can significantly induce apoptosis and cell death of melanoma cell lines [50] or sensitize glioma stem cells to other Bcl-2 inhibitors [51].